文献リスト

1) Lemery R, Brugada P, Della Bella P, et al. Ventricular fibrillation in six adults without overt heart disease. J Am Coll Cardiol. 1989; 13: 911-6

2) 相原直彦, 大江 透, 松久茂久雄, 他. 特発性心室細動の臨床および電気生理学的特徴. 心臓. 1990; 22 Suppl 2: 15

3) Aponte GE. The enigma of bangungut. Ann Intern Med. 1960; 52: 1258-63

4) Tatsanavivat P, Chirawatkul A, Klungboonkrong V, et al. Sudden and unexplained deaths in sleep (Lai Tai) of youngme in rural northeastern Thai­land. Int J Epidemiol. 1992; 21: 904-10

5) Gotoh K. A histopathologica study on the con­duction system of the so-called“pokkuri disease"(sudden unexpected cardiac death of unknown origin in Japan). Jpn Circ J. 1976; 40: 753-68

6) Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992; 20: 1391-6

7) Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consen­sus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005; 111: 659-70

8) 鎌倉史郎. Brugada症候群の予後―我が国の登録調査より―. 不整脈. 2005. 2005: 166-76

9) Eckardt L, Probst V, Smits JP, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation. 2005; 111: 257-63

10) Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology. Circulation. 2006; 114: e385-484

11) QT延長症候群(先天性・二次性)とBrugada症候群の診療に関するガイドライン. Circulation J. 2007; 70 Suppl IV: 1205-53

12) Wilde AA, Antzelevitch C, Borggrefe M, et al. Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J. 2002; 23: 1648-54

13) Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation. 2000; 101: 510-5

14) Nishizaki M, Sakurada H, Ashikaga T, et al. Effects of glucose-induced insulin secretion on ST segment elevation in the Brugada syndrome. J Cardiovasc Electrophysiol. 2003; 14: 243-9

15) Ikeda T, Abe A, Yusu S, et al. The full stomach test as a novel diagnostic technique for identify­ing patients at risk of Brugada syndrome. J Cardiovasc Electrophysiol. 2006; 17: 602-7

16) Nakazawa K, Sakurai T, Takagi A, et al. Clinical significance of electrocardiography recordings from a higher intercostal space for detection of the brugada sign. Circ J. 2004; 68: 1018-22

17) Morita H, Kusano KF, Miura D, et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation. 2008; 118: 1697-704

18) Brugada P, Brugada R, Mont L, et al. Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysi­ol. 2003; 14: 455-7

19) Eckardt L, Kirchhof P, Loh P, et al. Brugada syndrome and supraventricular tachyarrhy­th­mias: a novel association？ J Cardiovasc Electrophysiol. 2001; 12: 680-5

20) Giustetto C, Drago S, Demarchi PG, et al. Italian Association of Arrhythmology and Cardiostimu­lation (AIAC)-Piedmont Section. Europace. 2009; 11: 507-13

21) Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricu­lar fibrillation. Nature. 1998; 392: 293-6

22) Smits JP, Eckardt L, Probst V, et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol. 2002; 40: 350-6

23) Antzelevitch C, Pollevick GD, Cordeiro JM, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity charac­terized by ST-segment elevation, short QT inter­vals, and sudden cardiac death. Circulation. 2007; 115: 442-9

24) Watanabe A, Fukushima Kusano K, et al. Low-dose isoproterenol for repetitive ventri­cular arrhythmia in patients with Brugada syndrome. Eur Heart J. 2006; 27: 1579-83

25) Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syn­drome. Circulation. 2004; 110: 1731-7

26) Tsuchiya T, Ashikaga K, Honda T, et al. Preven­tion of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol. 2002; 13: 698-701

27) Sugao M, Fujiki A, Nishida K, et al. Repolari­zation dynamics in patients with idiopathic ventricular fibrillation: pharmaco­logical therapy with bepridil and disopyramide. J Cardiovasc Pharmacol. 2005; 45: 545-9

28) Haïssaguerre M, Extramiana F, Hocini M, et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation. 2003; 108: 925-8

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp